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Objectives: To determine the prevalence of retinopathy and its associated
factors in diabetic patients referred to a diabetes center in an Iranian city.
Methods: This was a cross-sectional, descriptiveeanalytical study in which a
researcher-made checklist was used to collect the data of patients with type 2
diabetes in 2015. The statistical population consisted of 11,770 health records of
diabetic patients registered in a second-level diabetes center. Of the 11,770
health records, 206 records with the most complete data about patients with
type 2 diabetes were selected through census method. Chi-square test and lo-
gistic regression through SPSS were used for data analysis.
Results: In this study, 93/206 diabetic patients (45.1%) had retinopathy. Female
sex, age over 60, lower education level, being housewife, family history of having
diabetes, longer years of having the disease, and higher level of hemoglobin A1c
(HbA1c) were associated with higher risk of retinopathy. However, the associa-
tion was statistically significant only for the HbA1c level (p  0.05).
Conclusion: According to this study, HbA1c level is a predictor of diabetes
complications. Therefore, it is necessary for health authorities to improve dia-
betes management through different strategies to prevent complications to
control blood sugar effectively.ail.com (M. Amiresmaili).
ase Control and Prevention. Published by Elsevier Korea LLC. This is an open access article
reativecommons.org/licenses/by-nc-nd/4.0/).
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Type 2 diabetes is a complex disease in which several
pathophysiological abnormalities are seen including
decreased insulin secretion, increased glucose production
in the liver, and increased insulin resistance. Type 2 dia-
betes epidemic is a major public health problem [1e3]. In
2003, the worldwide prevalence of diabetes among people
aged 20e79 years was 5.1% and is estimated to reach
6.3% by 2025 [4]. The prevalence of diabetes among
Iranian population between 20 years and 79 years of age
was 8.43%, which accounted for 4.4 million of the total
20e79-year-old population in 2013 [5]. Some of the main
causes of this growing trend can be attributed to popula-
tion growth, aging, urbanization, the prevalence of
obesity, and decreased physical activity [2].
Diabetes is associated with short- and long-term
complications, which in many cases are irreversible
[6]. One of the most important complications of diabetes
is diabetic retinopathy, which is a specific complication
of type 1 and 2 diabetes. This complication causes
thousands of people to become blind annually. The risk
of blindness from diabetic retinopathy in people with
diabetes is 29 times higher than in those without dia-
betes [7]. In developed nations, diabetes-related eye
diseases have been reported as the main cause of
blindness in adults younger than 75 years of age. This
disease accounts for approximately a quarter of regis-
tered blindness in the Western world. Visual impairment
due to diabetic retinopathy will have a large impact on
quality of life and imposes a heavy financial burden on
society every year [7,8]. It is estimated that more than
75% of patients with a 15e20-year history of diabetes
have retinopathy [9,10]. Many factors have been
mentioned as risk factors in the development of reti-
nopathy in diabetic patients. The most important ones
include older age, higher hemoglobin A1c (HbA1c)
level, duration of diabetes, hypertension, high body
mass index, smoking, poor blood glucose control,
pregnancy, and high blood cholesterol [11e13]. The
most effective treatment to prevent the progression of
diabetic retinopathy is “prevention”. Effective blood
sugar control prevents the progression of the disease.
Research has shown that for every 1% reduction in the
HbA1c level, the risk of microvascular diseases such as
retinopathy decreases by 37% [14].
After 20 years of having diabetes, nearly all patients
with type 1 diabetes and 58% of patients with type 2
diabetes show symptoms of retinopathy, and the wors-
ening of this problem may cause a loss of vision in
5e10% of the patients [15]. Considering the increasing
prevalence of diabetes and its debilitating complications
and the existence of multiple factors affecting the pro-
gression of the disease, this study was conducted to
investigate the prevalence of retinopathy and its related
factors among patients with type 2 diabetes attending adiabetes center in Kerman, Iran. A better understanding
of this issue and related factors can help provide more
disciplined and better ways to control this disease.2. Materials and methods
This was a descriptiveeanalytical, cross-sectional
study conducted in 2015. Health records of diabetic pa-
tients who were registered in a second-level diabetes care
center in Iran were used. From 11,770 health records of
diabetic patients, 206 health records with the most com-
plete information about the patients with type 2 diabetes
were selected. Inclusion criteria were having type 2 dia-
betes and having a full health record at the center where
the patients undergo regular eye examination and have
their HbA1c level recorded. Exclusion criteria were
having type 1 diabetes and incomplete information
related to retinopathy and HbA1c. For data collection, a
researcher-made checklist was used from which data on
variables such as age, sex, duration of diabetes, level of
education, employment status, family history, and the
level of HbA1c were extracted from the patients’ health
records. Data analysis was carried out using Chi-square
test and logistic regression through SPSS version 16
(SPSS Inc., Chicago, IL, USA). It should be noted that the
severity of retinopathywas not examined in this study due
to lack of access to required data.3. Results
According to the study results, of the 206 patients
with type 2 diabetes, 82.5% were women. The mean age
of patients was 60.4  8.3 years and their duration of
diabetes was 13 years. In this study, 45.1% of patients
(93/206) were diagnosed with retinopathy.
As shown in Table 1, a significant relationship be-
tween retinopathy and sex, age, disease history, family
history, education, and duration of the disease was not
observed. However, there was a significant relationship
between the level of HbA1c and diabetic retinopathy
(p Z 0.002).
In Table 2, demographic characteristics associated
with retinopathy were examined after adjusting for the
confounding effect using multivariate logistic regression
and no significant relationship was observed between
retinopathy and sex, age, history of disease, family
history, education, and duration of the disease. How-
ever, there was a significant relationship (p Z 0.006)
between the level of HbA1c and diabetic retinopathy.4. Discussion
In this study, the prevalence of retinopathy among
diabetic patients was 45.1%. Several studies about the
Table 1. Relationship between demographic characteristics of patients with type 2 diabetes and risk of retinopathy.
Variable Total
Retinopathy
p  0.05Yes, n (%) No, n (%)
Sex Men 36 18 (50) 18 (50) 0.322
Women 170 75 (44.1) 95 (55.9)
Age category (y) 30e49 14 3 (21.4) 11 (78.6) 0.073
50e59 78 32 (41) 46 (59)
 60 114 58 (50.9) 56 (49.1)
Level of education Illiterate 42 20 (47.6) 22 (52.4) 0.542
Primary 87 44 (50.6) 43 (49.4)
Guidance 24 9 (37.5) 15 (62.5)
High school 35 14 (40) 21 (60)
University 18 6 (33.3) 12 (66.7)
Working status Housewife 154 69 (44.8) 85 (55.2) 0.960
Practitioner 16 7 (43.8) 9 (56.2)
Retired 36 17 (47.2) 19 (52.8)
Family history of having diabetes Yes 98 50 (51) 48 (49) 0.070
No 108 43 (39.8) 65 (60.2)
Years with diabetes 1e5 46 17 (37) 29 (63) 0.12
6e10 45 15 (33.3) 30 (66.7)
11e15 50 21 (42) 29 (58)
> 15 65 40 (61.5) 25 (38.5)
Hemoglobin A1c level < 7 40 10 (25) 30 (75) 0.002
 7 125 66 (52.8) 59 (47.2)
298 R. Valizadeh, et alprevalence of retinopathy in diabetic patients have been
conducted in which the prevalence rate varied from 6.8%
to 50.3% [16e22]. In most studies that have been con-
ducted in different regions of Iran, the prevalence of
retinopathy has been reported between 30% and 40% [23].Table 2. Relationship between demographic characteristics of
adjusting for the confounding effect using multivariat
Variable Odd
Sex Men d
Women 0
Age category (y) 30e49 d
50e59 2
 60 2
Level of education Illiterate d
Primary 1
Guidance 1
High school 1
University 1
Working status Housewife d
Working 0
Retired 0
Family history of
having diabetes
No d
Yes 1
Years with diabetes 1e5 d
6e10 0
11e15 1
> 15 1
Hemoglobin A1c level < 7 d
 7 3In the study by Javadi et al [24], the prevalence of reti-
nopathy in Tehran was 37%. A Swedish study by Jerneld
and Algvere [25] indicated that 47% of patients with
diabetes had diabetic retinopathy and in those who had
diabetes for more than 30 years, this figure was 100%.patients with type 2 diabetes and risk of retinopathy after
e logistic regression.
s ratio Confidence interval p  0.05
d d
.3 0.05e2.03 0.233
d d
.04 0.4e9.4 0.360
.5 0.5e11.7 0.250
d d
.4 0.5e3.6 0.485
.3 0.4e4.9 0.664
.02 0.3e3.3 0.973
.1 0.2e5.9 0.862
d d
.4 0.05e3.7 0.440
.8 0.1e3.9 0.761
d d
.5 0.7e2.9 0.288
d d
.6 0.2e1.7 0.343
.5 0.5e4.01 0.462
.8 0.7e4.7 0.230
d d
.3 1.4e7.7 0.006
Prevalence of Retinopathy and Its Related Factors 299According to Henricsson et al [26], the prevalence of
retinopathy was significantly increased with increase in
HbA1c levels, and advanced retinopathy was associated
with a high level of HbA1c. In the study by Stratton et al
[13], the level of HbA1c was considered the strongest
factor in the incidence and severity of retinopathy
among patients with type 2 diabetes. In the study by Bek
et al [17], the level of HbA1c was one of the factors that
increased the risk of retinopathy. In this study, the
incidence of retinopathy in people with HbA1c levels of
7 or more was 3.3 times more than those with HbA1c
less than 7 and this relationship was statistically sig-
nificant. Moreover, in this study, the incidence of reti-
nopathy in people with a family history of the disease
was 1.5 times higher than those without a family history.
However, this relationship was not statistically signifi-
cant neither in the single-variable nor in the multivari-
able model. Similar studies also reported no significant
relationship between the prevalence of retinopathy and
family history of diabetes [24,27,28].
This study showed that the risk of retinopathy in-
creases with increasing age; in fact, the risk of retinop-
athy in age groups of 50e59 years and over 60 years was
2.4 times and 2.5 times more than that in the age group
of 30e49 years, respectively, although this relationship
was not statistically significant. These findings are
consistent with the findings of other studies [25,29].
Manaviat et al [23] showed that the relative risk of
retinopathy among people with a history of diabetes of
10 years or more is 1.5 times higher than those with a
history of diabetes of less than 10 years. Santos Bueso
et al [30] found out that prevalence of retinopathy in
patients who had a history of diabetes of 5e10 years and
in those who had a history of diabetes of more than
15 years was two times and 5.48 times more than those
with a history of diabetes less than 5 years, respectively.
The amount of retinopathy in patients older than 60 years
of age was 23% more than those under the age of 60.
Although we could not explore the statistically sig-
nificant relationship between the risk of retinopathy and
increased duration of the disease, the prevalence of
retinopathy raised with increasing the duration of the
disease in a way that people with a history of the disease
of 15 years or more were 1.8 times more likely to
develop retinopathy than the basic group with a history
of 1e5 years. Statistically, there was also no significant
difference in the prevalence of retinopathy between sex,
level of education, and employment. A study in India
indicated that risk factors associated with the prevalence
of retinopathy include age, duration of diabetes, being
male, level of HbA1c, and the presence of the ne-
phropathy [19]. However, in the study by Chen et al
[22], factors such as sex, age, education level, and
family history of diabetes were not significantly asso-
ciated with retinopathy. In the study by Jenchitr et al
[31], no relationships were found between the severity
of retinopathy and duration of diabetes as well asretinopathy and higher HbA1c levels. Duration of dia-
betes has been considered as a reflection of glycemic
control and other diabetic risk factors that patients have
been exposed to in the course of the disease [32,33].
In this study, the number of women attending to the
Kerman Diabetes Center was 82.5% more than that of
men. This difference could be due to that fact that the
center is open in the mornings when most men are at
work, unlike women who were mostly housewives. The
prevalence of retinopathy in men was 0.3 times more
than that in women, although a statistically significant
relationship was not observed. However, this could be
due to the fact that men had no access to the center as
they were at work in the mornings, and also the severity
of the disease in those who attended the center.
The prevalence of retinopathy in this study was
similar to other studies and small differences in statistics
could be due to lifestyle, geographical locations, and the
level of patients’ awareness about visual complications
of diabetes. This indicates the need for active involve-
ment of primary-level physicians in the management of
diabetes who in turn should be satisfied to remain and
work in primary health-care centers [34,35].
Diabetes Prevention and Control Program in the city of
Kerman was initiated in 2010, although it practically
started in 2011. One of the goals of this program is to
prevent the complications of diabetes such as diabetic
retinopathy, which is one of the most important compli-
cations of diabetes. This study showed that the prevalence
of retinopathy in patients with type 2 diabetes was 45.1%,
and there was a statistically significant relationship be-
tween the prevalence of retinopathy and the level of
HbA1c; in other words, the lack of control in the level of
HbA1c causes retinopathy. It could be said that the inci-
dence of retinopathy somehow reflects theweakness in the
management of diabetes, particularly at the primary level
of care that requires close examination of problems asso-
ciated with diabetes management and correcting them.Conflicts of interest
The authors have no conflicts of interest to declare.
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